SHFH — Scientist Home Future Health Income Statement
0.000.00%
Last trade - 00:00- $45.06m
- $44.99m
- $0.20m
Annual income statement for Scientist Home Future Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | — | USG | USG |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 0 | 0.121 | 0.204 |
| Cost of Revenue | |||
| Gross Profit | — | 0.053 | 0.082 |
| Selling / General / Administrative Expenses | |||
| Total Operating Expenses | — | 0.134 | 0.436 |
| Operating Profit | 0 | -0.013 | -0.232 |
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | — | -0.013 | -0.232 |
| Provision for Income Taxes | |||
| Net Income After Taxes | — | -0.015 | -0.232 |
| Net Income Before Extraordinary Items | |||
| Net Income | — | -0.015 | -0.232 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Dilution Adjustment | |||
| Diluted Net Income | 0 | -0.015 | -0.232 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | — | -0.001 | -0.01 |